Call for lead investigators for the DETERMINE trial

16 May 2023





DETERMINE (Determining Extended Therapeutic indications for Existing drugs in Rare Molecularly defined Indications using a National Evaluation platform trial) is a multi-drug, precision medicine trial for adults, teenagers and children with rare cancers. The DETERMINE trial is calling for motivated clinicians who may be interested and/or have experience with rare tumour types and would like to become a lead investigator for one of the treatment arms within the DETERMINE trial. If you are interested, please download the Expresssion of Interest form and send it to by 19 June 2023.

Find out more about DETERMINE